1.    Bay MJ, Kossoff EH, Lehmann CU, et al. Survey of aspirin use in Sturge-Weber syndrome. J Child Neurol. 2011;26(6):692-702.

2.    Ben Amitai D, Fichman S, Merlob P. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol. 2000;17(2):100-104.

3.    Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2024.

4.    Boos MD, Bozarth XL, Sidbury R, et al. Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome. J Am Acad Dermatol. 2020;83(4):1110-1117.

5.    Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port-wine stains in newborns: a review of 49 cases. Lasers Surg Med. 2007;39(7):563-568.

6.    Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873-877.

7.    Dutkiewicz AS, Ezzedine K, Mazereeuw-Hautier J, et al. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol. 2015;72(3):473-480.

8.    Faughnan ME, Mager JJ, Hetts SW, et al. Second International Guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173(12):989-1001.

9.    Giblin AV, Clover AJ, Athanassopoulos A, Budny PG. Pyogenic granuloma—the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007;60(9):1030-1035.

10. Guggisberg D, Hadj-Rabia S, Viney C, et al. Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol. 2004;140(9):1109-1115.

11. Happle R. Capillary malformations: a classification using specific names for specific skin disorders. J Eur Acad Dermatol Venereol. 2015;29(12):2295-2305.

12. Harris MN, Desai R, Chuang TY, et al. Lobular capillary hemangiomas: an epidemiologic report, with emphasis on cutaneous lesions. J Am Acad Dermatol. 2000;42(6):1012-1016.

13. Huiras EE, Barnes CJ, Eichenfield LF, et al. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics. 2005;116(3):e596-e600.

14. International Society for the Study of Vascular Anomalies. ISSVA classification of vascular anomalies. 2025. Accessed August 16, 2025. https://issva.org/classification

15. Kanada KN, Merin MR, Munden A, et al. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161(2):240-245.

16. Leboulanger N, Roger G, Caze A, et al. Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma. Int J Pediatr Otorhinolaryngol. 2008;72(6):953-958.

17. Lee J, Sinno H, Tahiri Y, Gilardino MS. Treatment options for cutaneous pyogenic granulomas: a review. J Plast Reconstr Aesthet Surg. 2011;64(9):1216-1220.

18. Lee MS, Liang MG, Mulliken JB. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol. 2013;69(4):589-594.

19. Mazereeuw-Hautier J, Syed S, Harper J. Bilateral facial capillary malformation associated with eye and brain abnormalities. Arch Dermatol. 2006;142(8):994-998.

20. Mazoyer E, Enjolras O, Bisdorff A, et al. Coagulation disorders in patients with venous malformation of limbs and trunk. Arch Dermatol. 2008;144(7):861-867.

21. Nguyen CM, Yohn JJ, Huff C, et al. Facial port-wine stains in childhood: prediction of the rate of improvement as a function of age, size, location, and number of pulsed dye laser treatments. Br J Dermatol. 1998;138(5):821-825.

22. Nguyen JT, Koerper MA, Hess CP, et al. Aspirin therapy in venous malformation: a retrospective cohort study. Pediatr Dermatol. 2014;31(5):556-560.

23. Peters DA, Courtemanche DJ, Heran MKS, et al. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast Reconstr Surg. 2006;118(6):1441-1446.

24. Redondo P, Aguado L, Martinez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: part II. J Am Acad Dermatol. 2011;65(5):909-923.

25. Sabbà C, Pasculli G, Lenato GM, et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007;5(6):1149-1157.

26. Sapp JC, Turner JT, van de Kamp JM, et al. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome). Am J Med Genet A. 2007;143A(24):2944-2958.

27. Seukeran DC, Collins P, Sheehan-Dare RA. Adverse reactions following pulsed tunable dye laser treatment of port-wine stains. Br J Dermatol. 1997;136(5):725-729.

28. Shiels WE 2nd, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008;43(1):136-139.

29. Sudarsanam A, Ardern-Holmes SL. Sturge-Weber syndrome: from the past to the present. Eur J Paediatr Neurol. 2014;18(3):257-266.

30. Waelchli R, Aylett SE, Robinson K, et al. New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol. 2014;171(4):861-867.

31. Zwerink LGJM, Te Loo DMWM, Praster R, et al. Aberrant venous anatomy as a risk factor for thromboembolic events in Klippel-Trénaunay syndrome. J Am Acad Dermatol. 2021;84(6):1470-1472.